Skip to main content
Erschienen in: Medical Oncology 10/2014

01.10.2014 | Original Paper

Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population

verfasst von: Shadi Amininia, Mohammad Hashemi, Mahboubeh Ebrahimi, Mohammad Ali Mashhadi, Seyed Mehdi Hashemi, Mohsen Taheri, Saeid Ghavami

Erschienen in: Medical Oncology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Cyclin E1 (CCNE1) is a key proto-oncogene. The present study aimed to investigate the effects of single nucleotide polymorphisms in CCNE1 on the risk of breast cancer (BC) in an Iranian population in southeast of Iran. A total of 491 subjects including 266 BC patients and 225 healthy control women were participated in the study. Genotyping of CCNE1 rs3218073 and 72010703 polymorphisms was done using allele-specific polymerase chain reaction (AS-PCR) and rs1406 by PCR–RFLP method.Our findings showed that rs1406 C/A polymorphism increased the risk of BC in codominant (OR 1.60, 95 % CI 1.05–2.43, p = 0.032 CA vs CC; OR 2.35, 95 % CI 1.23–4.49, p = 0.011 AA vs CC) and dominant (OR 1.69, 95 % CI 1.22–2.56, p = 0.012 CA + AA vs CC) inheritance models. The rs1406 A allele increased the risk of BC (OR 1.37, 95 % CI 1.06–1.76, p = 0.019) in comparison with C allele. On the other hand, CCNE1 rs72010703 (4-bp I/D) and rs3218073 polymorphisms did not show any significant association with BC. This study indicates that CCNE1 rs1406 polymorphism may contribute to BC risk.
Literatur
1.
Zurück zum Zitat Wu JT, Kral JG. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res. 2005;123(1):158–69.PubMedCrossRef Wu JT, Kral JG. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res. 2005;123(1):158–69.PubMedCrossRef
2.
Zurück zum Zitat Turashvili G, Bouchal J, Burkadze G, et al. Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):63–8.PubMedCrossRef Turashvili G, Bouchal J, Burkadze G, et al. Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):63–8.PubMedCrossRef
3.
Zurück zum Zitat Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237–48.PubMedCrossRef Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237–48.PubMedCrossRef
4.
Zurück zum Zitat Babu GR, Samari G, Cohen SP, et al. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev. 2011;12(7):1647–55.PubMed Babu GR, Samari G, Cohen SP, et al. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev. 2011;12(7):1647–55.PubMed
5.
Zurück zum Zitat Kolahdoozan S, Sadjadi A, Radmard AR, et al. Five common cancers in Iran. Arch Iran Med. 2010;13(2):143–6.PubMed Kolahdoozan S, Sadjadi A, Radmard AR, et al. Five common cancers in Iran. Arch Iran Med. 2010;13(2):143–6.PubMed
6.
Zurück zum Zitat Hashemi M, Fazaeli A, Ghavami S, et al. Functional polymorphisms of FAS and FASL gene and risk of breast cancer–pilot study of 134 cases. PLoS one. 2013;8(1):e53075.PubMedCrossRefPubMedCentral Hashemi M, Fazaeli A, Ghavami S, et al. Functional polymorphisms of FAS and FASL gene and risk of breast cancer–pilot study of 134 cases. PLoS one. 2013;8(1):e53075.PubMedCrossRefPubMedCentral
7.
Zurück zum Zitat Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 2012;6(6):797–803.PubMedCrossRef Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 2012;6(6):797–803.PubMedCrossRef
8.
Zurück zum Zitat Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8–652 6 N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 2012;505(1):176–9.PubMedCrossRef Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8–652 6 N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 2012;505(1):176–9.PubMedCrossRef
9.
Zurück zum Zitat Eskandari-Nasab E, Hashemi M, Rezaei H, et al. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep. 2012;39(12):10531–9.PubMedCrossRef Eskandari-Nasab E, Hashemi M, Rezaei H, et al. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep. 2012;39(12):10531–9.PubMedCrossRef
10.
Zurück zum Zitat Omrani M, Hashemi M, Eskanadri-Nasab E, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014;8(2):257–65.CrossRef Omrani M, Hashemi M, Eskanadri-Nasab E, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014;8(2):257–65.CrossRef
11.
Zurück zum Zitat Hashemi M, Amininia S, Ebrahimi M, et al. Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population. Med Oncol. 2014;31(8):111.PubMedCrossRef Hashemi M, Amininia S, Ebrahimi M, et al. Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population. Med Oncol. 2014;31(8):111.PubMedCrossRef
12.
Zurück zum Zitat Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1(3):222–31.PubMedCrossRef Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1(3):222–31.PubMedCrossRef
13.
Zurück zum Zitat Ezhevsky SA, Ho A, Becker-Hapak M, et al. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol. 2001;21(14):4773–84.PubMedCrossRefPubMedCentral Ezhevsky SA, Ho A, Becker-Hapak M, et al. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol. 2001;21(14):4773–84.PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science. 1989;246(4930):629–34.PubMedCrossRef Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science. 1989;246(4930):629–34.PubMedCrossRef
15.
Zurück zum Zitat Leung SY, Ho C, Tu IP, et al. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod Pathol. 2006;19(6):854–63.PubMed Leung SY, Ho C, Tu IP, et al. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod Pathol. 2006;19(6):854–63.PubMed
17.
Zurück zum Zitat Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401(6750):297–300.PubMedCrossRef Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401(6750):297–300.PubMedCrossRef
18.
Zurück zum Zitat Song H, Hogdall E, Ramus SJ, et al. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res. 2008;14(4):1090–5.PubMedCrossRefPubMedCentral Song H, Hogdall E, Ramus SJ, et al. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res. 2008;14(4):1090–5.PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Han JY, Wang H, Xie YT, et al. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women. PLoS one. 2012;7(11):e49296.PubMedCrossRefPubMedCentral Han JY, Wang H, Xie YT, et al. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women. PLoS one. 2012;7(11):e49296.PubMedCrossRefPubMedCentral
20.
Zurück zum Zitat Liu Y, Cai H, Liu J, et al. A miR-151 binding site polymorphism in the 3′-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2013;432(4):660–5.PubMedCrossRef Liu Y, Cai H, Liu J, et al. A miR-151 binding site polymorphism in the 3′-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2013;432(4):660–5.PubMedCrossRef
21.
Zurück zum Zitat Driver KE, Song H, Lesueur F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis. 2008;29(2):333–41.PubMedCrossRefPubMedCentral Driver KE, Song H, Lesueur F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis. 2008;29(2):333–41.PubMedCrossRefPubMedCentral
22.
Zurück zum Zitat Olson JE, Wang X, Pankratz VS, et al. Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat. 2011;125(1):221–8.PubMedCrossRefPubMedCentral Olson JE, Wang X, Pankratz VS, et al. Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat. 2011;125(1):221–8.PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978–84.PubMedCrossRefPubMedCentral Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978–84.PubMedCrossRefPubMedCentral
24.
Zurück zum Zitat Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan. Southeast Iran. DNA Cell Biol. 2012;31(5):672–7.CrossRef Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan. Southeast Iran. DNA Cell Biol. 2012;31(5):672–7.CrossRef
25.
Zurück zum Zitat Murali A, Nalinakumari KR, Thomas S, et al. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014;52(7):652–8.PubMedCrossRef Murali A, Nalinakumari KR, Thomas S, et al. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014;52(7):652–8.PubMedCrossRef
26.
Zurück zum Zitat Azzato EM, Driver KE, Lesueur F, et al. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast Cancer Res. 2008;10(3):R47.PubMedCrossRefPubMedCentral Azzato EM, Driver KE, Lesueur F, et al. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast Cancer Res. 2008;10(3):R47.PubMedCrossRefPubMedCentral
Metadaten
Titel
Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population
verfasst von
Shadi Amininia
Mohammad Hashemi
Mahboubeh Ebrahimi
Mohammad Ali Mashhadi
Seyed Mehdi Hashemi
Mohsen Taheri
Saeid Ghavami
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 10/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0189-z

Weitere Artikel der Ausgabe 10/2014

Medical Oncology 10/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.